Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bee Venom Toxic Effect on MDA-MB-231 Breast Cancer Cells and Caenorhabditis Elegans.
Barros YVR, de Andrade AO, da Silva LPD, Pedroza LAL, Bezerra IC, Cavalcanti IDL, de Britto Lira Nogueira MC, Mousinho KC, Antoniolli AR, Alves LC, de Lima Filho JL, Moura AV, Rosini Silva ÁA, de Melo Porcari A, Gubert P. Barros YVR, et al. Among authors: cavalcanti idl. Anticancer Agents Med Chem. 2024;24(10):798-811. doi: 10.2174/0118715206291634240312062957. Anticancer Agents Med Chem. 2024. PMID: 38500290
Ceftazidime and Usnic Acid Encapsulated in Chitosan-Coated Liposomes for Oral Administration against Colorectal Cancer-Inducing Escherichia coli.
de Souza JB, de Lacerda Coriolano D, Dos Santos Silva RC, da Costa Júnior SD, de Almeida Campos LA, Cavalcanti IDL, Lira Nogueira MCB, Pereira VRA, Brelaz-de-Castro MCA, Cavalcanti IMF. de Souza JB, et al. Among authors: cavalcanti idl. Pharmaceuticals (Basel). 2024 Jun 19;17(6):802. doi: 10.3390/ph17060802. Pharmaceuticals (Basel). 2024. PMID: 38931469 Free PMC article.
Does Oncocalyxone A (oncoA) have intrinsic fluorescence?
Cavalcanti IDL, Cabral Filho PE, Fontes A, Ximenes RM, Souto FO, Pessoa ODL, Lira Nogueira MCB, Santos Magalhães NS. Cavalcanti IDL, et al. Photodiagnosis Photodyn Ther. 2022 Sep;39:102869. doi: 10.1016/j.pdpdt.2022.102869. Epub 2022 Apr 21. Photodiagnosis Photodyn Ther. 2022. PMID: 35462056
Nanotechnology and tuberculosis: An old disease with new treatment strategies.
Macêdo DCDS, Cavalcanti IDL, Medeiros SMFRDS, Souza JB, Lira Nogueira MCB, Cavalcanti IMF. Macêdo DCDS, et al. Among authors: cavalcanti idl. Tuberculosis (Edinb). 2022 Jul;135:102208. doi: 10.1016/j.tube.2022.102208. Epub 2022 May 7. Tuberculosis (Edinb). 2022. PMID: 35567896 Review.
Impact of COVID-19 on cancer patients: A review.
Cavalcanti IDL, Soares JCS. Cavalcanti IDL, et al. Asia Pac J Clin Oncol. 2021 Jun;17(3):186-192. doi: 10.1111/ajco.13445. Epub 2020 Sep 24. Asia Pac J Clin Oncol. 2021. PMID: 32970923 Review.
Synergism between metallic nanoparticles and antibiotics.
Agreles MAA, Cavalcanti IDL, Cavalcanti IMF. Agreles MAA, et al. Among authors: cavalcanti idl. Appl Microbiol Biotechnol. 2022 Jun;106(11):3973-3984. doi: 10.1007/s00253-022-12001-1. Epub 2022 Jun 7. Appl Microbiol Biotechnol. 2022. PMID: 35670851 Review.
Nanotechnology and COVID-19: quo vadis?.
Tavares JL, Cavalcanti IDL, Santos Magalhães NS, Lira Nogueira MCB. Tavares JL, et al. Among authors: cavalcanti idl. J Nanopart Res. 2022;24(3):62. doi: 10.1007/s11051-022-05452-0. Epub 2022 Mar 7. J Nanopart Res. 2022. PMID: 35283662 Free PMC article. Review.
19 results